Edition:
India

Stratec Biomedical AG (SBSG.DE)

SBSG.DE on Xetra

66.00EUR
20 Nov 2017
Change (% chg)

€1.39 (+2.15%)
Prev Close
€64.61
Open
€64.50
Day's High
€67.58
Day's Low
€64.50
Volume
16,699
Avg. Vol
12,070
52-wk High
€67.58
52-wk Low
€41.30

Summary

Name Age Since Current Position

Fred Brueckner

74 2000 Chairman of the Supervisory Board

Marcus Wolfinger

50 2010 Chairman of the Management Board, Chief Executive Officer

Rainer Baule

Vice Chairman of the Supervisory Board

Robert Siegle

50 2011 Director of Finance and Human Resources, Member of the Board of Management

Claus Vielsack

50 2014 Member of the Management Board, Director of Product Development

Stefanie Remmele

39 2014 Member of the Supervisory Board

Jan Keppeler

2017 Head of Investor Relations & Corporate Communications

Biographies

Name Description

Fred Brueckner

Mr. Fred K. Brueckner has been Chairman of the Supervisory Board of STRATEC Biomedical AG since March 2000. Before that, he served as Member of the Supervisory Board at the Company from May 1998. Mr. Brueckner is a Chemical Engineer and Independent Management Consultant.

Marcus Wolfinger

Mr. Marcus Wolfinger has been Chairman of the Management Board and Chief Executive Officer at STRATEC Biomedical AG since April 1, 2010. Prior to that he served as Chief Financial Officer and Member of the Management Board of the Company from July 1, 1999. He joined STRATEC Biomedical Systems AG on March 1, 1998 as Commercial Manager. Mr. Wolfinger holds a degree in Business Administration.

Rainer Baule

Mr. Rainer Baule serves as Vice Chairman of the Supervisory Board at STRATEC Biomedical AG. He joined the Company's Supervisory Board on June 14, 2017.

Robert Siegle

Dr. Robert Siegle has been Director of Finance and Human Resources and Member of the Board of Management at STRATEC Biomedical AG since February 1, 2011. Prior to that, he served as Deputy Chairman of the Supervisory Board at the Company from May 1998 until December 31, 2010. Dr. Siegle is a Self-Employed Lawyer. He has been Member of the Management of STRATEC Molecular GmbH since December 2012 and Member of the Administrative Board of STRATEC Biomedical Switzerland AG since March 2014. Dr. Siegle was Member of the Board of STRATEC Biomedical UK, Ltd. until July 2014.

Claus Vielsack

Dr. Claus Vielsack has been Member of the Management Board and Director of Product Development at STRATEC Biomedical AG since February 15, 2014. He joined the Company on September 1, 1998 and has held various senior product development positions. He holds a degree in Chemistry.

Stefanie Remmele

Prof. Dr. Stefanie Remmele has been Member of the Supervisory Board of STRATEC Biomedical AG since June 18, 2014. She graduated in Electrical Engineering, She has been Professor for medical engineering at the Hochschule Landshut, Germany – University of Applied Sciences.

Jan Keppeler

Basic Compensation

Name Fiscal Year Total

Fred Brueckner

54,000

Marcus Wolfinger

874,000

Rainer Baule

--

Robert Siegle

612,000

Claus Vielsack

566,000

Stefanie Remmele

29,000

Jan Keppeler

--
As Of  31 Dec 2016